abstract |
Therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid-1 (MPIF-1) inhibitory factor polypeptide (previously called MIP-3 and chymosin beta-8 (Ckbeta-8 or ckb-8) are described )), as well as the MPIF-1 polypeptide itself, such as vectors, host cells and recombinant methods to produce them. |